GRACE QUIOGUE: Open Payments
NPI 1316587421 · ROSEVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 8 payments from 8 companies in 2025. Trend: 2023 $166 · 2024 $608 · 2025 $157
Food & beverage: $157
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| Incyte Corporation | 1 | $20 |
| Kite Pharma, Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| BeiGene USA, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: Epkinly, CARVYKTI, Polivy, JAKAFI, Yescarta, ORGOVYX, TEVIMBRA, Padcev.
Industry payments across MI — which companies pay providers there.
